Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Five modifiable risk factors are associated with cardiovascular disease and death from any cause. Studies using individual-level data to evaluate the regional and sex-specific prevalence of the risk factors and their effect on these outcomes are lacking. METHODS: We pooled and harmonized individual-level data from 112 cohort studies conducted in 34 countries and 8 geographic regions participating in the Global Cardiovascular Risk Consortium. We examined associations between the risk factors (body-mass index, systolic blood pressure, non-high-density lipoprotein cholesterol, current smoking, and diabetes) and incident cardiovascular disease and death from any cause using Cox regression analyses, stratified according to geographic region, age, and sex. Population-attributable fractions were estimated for the 10-year incidence of cardiovascular disease and 10-year all-cause mortality. RESULTS: Among 1,518,028 participants (54.1% of whom were women) with a median age of 54.4 years, regional variations in the prevalence of the five modifiable risk factors were noted. Incident cardiovascular disease occurred in 80,596 participants during a median follow-up of 7.3 years (maximum, 47.3), and 177,369 participants died during a median follow-up of 8.7 years (maximum, 47.6). For all five risk factors combined, the aggregate global population-attributable fraction of the 10-year incidence of cardiovascular disease was 57.2% (95% confidence interval [CI], 52.4 to 62.1) among women and 52.6% (95% CI, 49.0 to 56.1) among men, and the corresponding values for 10-year all-cause mortality were 22.2% (95% CI, 16.8 to 27.5) and 19.1% (95% CI, 14.6 to 23.6). CONCLUSIONS: Harmonized individual-level data from a global cohort showed that 57.2% and 52.6% of cases of incident cardiovascular disease among women and men, respectively, and 22.2% and 19.1% of deaths from any cause among women and men, respectively, may be attributable to five modifiable risk factors. (Funded by the German Center for Cardiovascular Research (DZHK); ClinicalTrials.gov number, NCT05466825.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As well as the significant improvement in diabetic control, cardiometabolic risk was also improved by a significant reduction in SBP which was recorded across the cohort, specifically for those who had one or more co-existing medical conditions and for those who had a diagnosis of T2D of less than 6 years29.”
From mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes (2025) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.010 · Cited by 11,449
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138 · cited 1×
“Although very low non-HDL cholesterol concentrations are related to reduced CVD events, 25,26 some observations point towards higher all-cause mortality rates in individuals with very low levels at least in longer-term follow-up.”
(2010) · University of Twente Research Information · Cited by 6,037
Auditory and non-auditory effects of noise on health
Basner, M., Babisch, W., Davis, A., Brink, M., Clark, C., Janssen, S., & Stansfeld, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61613-x · Cited by 2,473 · cited 1×
“Environmental and exposomal factors such as physical activity 18 , alcohol consumption 28 , air pollution 29 , climate and noise 30 , educational level 3 or psychosocial risk factors including depression 31 impact CVD risk.”
Global burden of blood-pressure-related disease, 2001
Lawes, C. M., Hoorn, S. V., & Rodgers, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60655-8 · Cited by 2,330 · cited 3×
“While tobacco consumption is strongly associated with premature mortality, elevated blood pressure and cholesterol are more specifically related to CVD. 7 A tailored reduction in the burden of CVD and all-cause mortality for persons and populations can be achieved with better understanding of the region-and sex-specif…”
InfluentialEfficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Robinson, J. G., Farnier, M., Krempf, M., Bergeron, J., Luc, G., Averna, M., Stroes, E. S., Langslet, G., Raal, F. J., El Shahawy, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501031 · Cited by 2,296 · cited 1×
“Although very low non-HDL cholesterol concentrations are related to reduced CVD events, 25,26 some observations point towards higher all-cause mortality rates in individuals with very low levels at least in longer-term follow-up.”
The Global Burden of Cardiovascular Diseases and Risk
Vaduganathan, M., Mensah, G. A., Turco, J. V., Fuster, V., & Roth, G. A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.005 · Cited by 2,217
Cited by
Items 101–200 of 980
Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes
Leong, D. P., Fradet, V., Niazi, T. M., Selvanayagam, J. B., Sabbagh, R., Higano, C. S., Agapay, S., Rangarajan, S., Mian, R. I., Nakashima, C. A. K., et al. (2024) · JACC CardioOncology · doi:10.1016/j.jaccao.2024.07.011 · Cited by 18
Endothelial FOSL1 drives angiotensin II-induced myocardial injury via AT1R-upregulated MYH9
Zhao, W., Qian, Y., Zhang, Y., Yang, A., Cao, J.-X., Qian, H.-Y., Liu, Y., & Zhu, W.-Z. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01410-9 · Cited by 17
Combet, E., Haag, L., Richardson, J., Haig, C. E., Cunningham, Y., Fraser, H. L., Brosnahan, N., Ibbotson, T. R., Ormerod, J. A., White, C., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03384-x · Cited by 15
Mohammadnia, N., Wesselink, B. E., Bax, W. A., Nidorf, S. M., Mosterd, A., Fiolet, A. T. L., Cetinyurek‐Yavuz, A., Thompson, P. L., Bangdiwala, S. I., Eikelboom, J. W., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.038687 · Cited by 18
Wei, Z., Wei, K., Yang, M., Ying, M., Yin, Z., Wang, N., & Zhang, L. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117395 · Cited by 16
Grave, C., Bonaldi, C., Carcaillon‐Bentata, L., Gabet, A., Halimi, J., Tzourio, C., Béjot, Y., Torres, M. J., Steg, P. G., Durand‐Zaleski, I., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.23760 · Cited by 17
Yacamán-Méndez, D., Zhou, M., Brynedal, B., Guðjónsdóttir, H., Tynelius, P., Lagerros, Y. T., & Lager, A. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf013 · Cited by 22
Wu, S., Wang, Y., Wang, J., Feng, J. H., Li, F., Lin, L., Ruan, C., Nie, Z., Tian, J., & Jin, C. (2025) · BMC Medicine · doi:10.1186/s12916-025-03923-4 · Cited by 17
Schwalm, J.-D., Joseph, P. G., Leong, D. P., López-López, J., Onuma, O. K., Bhatt, P., Avezum, Á., Walli-Attaei, M., McKee, M., & Yusuf, S. (2025) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2024.100964 · Cited by 26
Endothelial Krüppel-like factor 2/4: Regulation and function in cardiovascular diseases
Gao, J., Pan, H., Guo, X., Huang, Y., & Luo, J. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111699 · Cited by 22
Lee, H., Huang, X., Khan, S. S., Son, D., Lee, H.-H., Kim, E., Lloyd‐Jones, D. M., Kim, H. C., & Greenland, P. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.07.014 · Cited by 17
Trafficking and effect of released DNA on cGAS-STING signaling pathway and cardiovascular disease
Zhou, Z., Ouyang, C., Chen, Q., Ren, Z., Guo, X., Lei, M., Liu, C., & Yang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1287130 · Cited by 15
Barbosa, A. R., Pais, S., Marreiros, A., & Correia, M. (2024) · Nutrients · doi:10.3390/nu16152443 · Cited by 16
Meta-analysis of postoperative incision infection risk factors in colorectal cancer surgery
Li, J., Zhao, H., & Liu, J. (2024) · Frontiers in Surgery · doi:10.3389/fsurg.2024.1415357 · Cited by 15
Jiang, N., Chen, G., Zhou, F., Ma, B., Zhao, C., & Liu, H. (2024) · Journal of Materials Chemistry C · doi:10.1039/d4tc02494j · Cited by 17
Zhong, L., Xie, B., Wang, H., & Ji, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-78610-0 · Cited by 15
Li, J., Man, Q., Wang, Y., Cui, M., Li, J., Xu, K., Liu, Z., Li, J., Chen, X., Suo, C., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103585 · Cited by 17
Knauss, H. M., Kovell, L. C., Miller, E. R., Appel, L. J., Mukamal, K. J., Plante, T. B., & Juraschek, S. P. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.100980 · Cited by 16
Insights Into Heart-Tumor Interactions in Heart Failure
Caller, T., Moore, K. J., Lehmann, L., Wu, S. M., & Leor, J. (2025) · Circulation Research · doi:10.1161/circresaha.124.325490 · Cited by 15
The Forgotten Connection: Mental Health and Cardiovascular Disease
Sanchis‐Gomar, F., & Lippi, G. (2024) · Heart and Mind · doi:10.4103/hm.hm-d-24-00096 · Cited by 16
Ostrominski, J. W., & Powell‐Wiley, T. M. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01182-3 · Cited by 15
Vyas, M. V., Redditt, V. J., Mohamed, S., Abraha, M., Sheth, J., Shah, B. R., Ko, D. T., & Ke, C. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.02.011 · Cited by 19
The effect of lipid-lowering therapy on lipid-related residual risk factors: a prospective study
Li, Z., Gao, Y., Lu, Q., Yin, Z., Zhang, S., Zhang, W., Sui, Y., Xu, Y.-L., Li, J., Dou, K., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02078-0 · Cited by 15
Hammoudeh, A. J., Jallad, M., Khader, Y. S., Badaineh, Y., Tabbalat, R. A., Zammar, H., Al-Makhamreh, H. K., Basha, A. S., Alatteili, L., Abuhalimeh, R., et al. (2024) · Global Heart · doi:10.5334/gh.1341 · Cited by 14
Chen, J., Zhang, M., Wang, Y., Zhang, Z., Gao, S., & Zhang, Y. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1425843 · Cited by 16
Mesnier, J., Giovachini, L., Ducrocq, G., Danchin, N., Ford, I., Tendera, M., Feldman, L. J., Ferrari, R., Tardif, J., Fox, K. M., et al. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf222 · Cited by 16
Experimental evidence on colchicine's mode of action in human carotid artery plaques
von Ehr, A., Steenbuck, I. D., Häfele, C., Remmersmann, F., Vico, T. A., Ehlert, C. A., Lindner, D., Wolf, D., Tholen, S., Schilling, O., et al. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119239 · Cited by 14
Huang, Q., Yan, H., Chen, H., Xie, J.-H., Gao, J., Li, Z., & Mao, C. (2025) · Heart · doi:10.1136/heartjnl-2024-325362 · Cited by 15
FAKTOR-FAKTOR RISIKO PENYAKIT KARDIOVASKULAR: ARTIKEL REVIEW
Handayani, W. (2025) · Pengembangan Ilmu dan Praktik Kesehatan · doi:10.56586/pipk.v4i3.465 · Cited by 14
Jianu, N., Nițu, E.-T., Merlan, C., Nour, A., Buda, S., Suciu, M., Luca, S. A., Sbârcea, L., Andor, M., & Buda, V. O. (2025) · Pharmaceuticals · doi:10.3390/ph18081150 · Cited by 20
Johnsen, L.-H., Herder, M., Vangberg, T. R., Isaksen, J. G., & Mathiesen, E. B. (2023) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2023.107399 · Cited by 13
Nair, L., Asuzu, P., & Dagogo-Jack, S. E. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae116 · Cited by 14
Li, C., Li, Y., Wu, S., Gui, L., Li, J., Zhao, Y., Cai, H., Jia, S., Song, M., Fu, Q., et al. (2024) · Small Methods · doi:10.1002/smtd.202400738 · Cited by 13
Wang, Z., Lu, H., Li, Y., Huang, S., Zhang, M., Wen, Y., & Shang, D. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.161 · Cited by 13
Role of naringin in the treatment of atherosclerosis
Lu, Y., Li, D., Xu, J.-M., & Zhou, S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1451445 · Cited by 13
Ye, X., Liang, M., Chen, Z., Jiang, X., Xie, M., Xie, X., Lan, G., Lu, X., Huang, Z., Xu, T., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-20443-7 · Cited by 13
Liang, Y., Liu, Y., Tan, Q., Zhou, K., Wu, Y., & Li, Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02339-y · Cited by 14
Normal-weight obesity subtypes and 10-year risks of major vascular diseases in 0.3 million adults
Wang, M., Xu, K., Yang, J., Bennett, D., Du, H., & Liu, X. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.12.027 · Cited by 13
Role of Histone Deacetylase and Inhibitors in Cardiovascular Diseases
Zhang, L., Wang, Y., Wen, R., Zhang, T., & Yang, N. (2025) · Cell Proliferation · doi:10.1111/cpr.70077 · Cited by 13
Risk factors for cardiovascular disease: the known unknown
Arita, V. A., Beigrezaei, S., & Franco, O. H. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad392 · Cited by 14
Molavizadeh, D., Cheraghloo, N., Tohidi, M., Azizi, F., & Hadaegh, F. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02387-9 · Cited by 15
Guo, W. S., Huang, R., Bian, J., Liao, Q., You, J., Xi, Y., Wang, Y., Wen, D., Fan, X., Zhou, C., et al. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.151104 · Cited by 13
Primary Prevention of Cardiovascular Disease in Asia: Opportunities and Solutions
Dalakoti, M., Lin, N. H. Y., Yap, J. J. L., Cader, F. A., Prajapati, D., Lee, D. P. H., Shariff, R. E. R., Cuenza, L. R., Honda, S., Malis, V., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101676 · Cited by 15
Wang, Y., Wen, Q., Luo, S., Tang, L., Zhan, S., Cao, J., Wang, S., & Chen, Q. (2025) · Health Data Science · doi:10.34133/hds.0161 · Cited by 16
Atherogenic dyslipidemia and incident cardiovascular events in high-risk hypertension
Kazibwe, R., Jehopio, J., Schaich, C. L., Rikhi, R. R., Mirzai, S., Chevli, P. A., Namutebi, J. H., Chebrolu, S., O'Connor, S., Yeboah, J., et al. (2025) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2025.05.006 · Cited by 12
Neutrophil extracellular traps as therapeutics target in vascular aging
Mao, J., Wu, S., Yan, Z.-L., Huang, G., & Yu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1657938 · Cited by 13
Liu, Z., Wang, H., Yang, Z., Lu, Y., Wang, J., & Zou, C. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.076 · Cited by 12
Unexplained Residual Risk In Type 2 Diabetes: How Big Is The Problem?
Neppala, S., Rajan, J., Yang, E., & DeFronzo, R. A. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02055-0 · Cited by 12
Impact of Cancer, Inflammation, and No Standard Risk Factors in Patients With Myocardial Infarction
Yaginuma, H., Saito, Y., Goto, H., Asada, K., Shiko, Y., Sato, T., Hashimoto, O., Kitahara, H., & Kobayashi, Y. (2024) · JACC Asia · doi:10.1016/j.jacasi.2024.03.008 · Cited by 12
Gerber, F., Gupta, R., Lejone, T. I., Tahirsylaj, T., Lee, T. T., Sanchez-Samaniego, G., Kohler, M., Haldemann, M. I., Raeber, F., Chitja, M., et al. (2024) · Trials · doi:10.1186/s13063-024-08226-2 · Cited by 14
Geschlechterspezifische Aspekte kardiovaskulärer Erkrankungen
Baessler, A., Bauer, P., Becker, M., Berrisch-Rahmel, S., Goldmann, B. U., Grünig, E., Hamm, C., Meder, B., Kindermann, I., Ong, P., et al. (2024) · Die Kardiologie · doi:10.1007/s12181-024-00694-9 · Cited by 11
Nagasawa, H., Suzuki, S., Kobayashi, T., Otsuka, T., Okuma, T., Matsushita, S., Amano, A., Shimizu, Y., Suzuki, Y., & Ueda, S. (2024) · Hypertension Research · doi:10.1038/s41440-024-01895-1 · Cited by 12
Menopause-related changes in vascular signaling by sex hormones
Li, T., Thoen, Z. E., Applebaum, J. M., & Khalil, R. A. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103526 · Cited by 13
Bi, S.-Z., Sun, W.-D., Zhu, X., Lai, S.-Y., An-Liu, Zhang, C.-Y., & Li, J.-H. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117790 · Cited by 11
Otto, C. M., Abdullah, A. R., Davis, L. L., Ferrari, V. A., Fremes, S. E., Mukherjee, D., Prestera, L., & Ziaeian, B. (2025) · Circulation · doi:10.1161/cir.0000000000001383 · Cited by 18
Homoródi, N., Varga, É., Szabó, Z., Sztanek, F., & Harangi, M. (2025) · Biomedicines · doi:10.3390/biomedicines13112595 · Cited by 15
“This is primarily due to the high prevalence of risk factors such as obesity, hypertension, hyperlipidemia, smoking, and type 2 diabetes mellitus (T2DM) [2].”
Brusca, S. B., & Albert, M. A. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00386-1 · Cited by 11
Cortese, S., & Fava, C. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.4126 · Cited by 11
Xing, Y., Xie, S.-Y., Deng, W., & Tang, Q. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116936 · Cited by 13
Adapting cardiovascular risk prediction models to different populations: the need for recalibration
Pennells, L. A. M., Kaptoge, S. K., & Angelantonio, E. D. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad748 · Cited by 11
Modifiable Risk Factors and Cardiovascular Outcomes
Ou, D., Hu, C., & Huang, S. (2023) · New England Journal of Medicine · doi:10.1056/nejmc2312596 · Cited by 11
Ouro, A., Rodríguez-Díaz, A., López-González, T., Romaus‐Sanjurjo, D., Estévez‐Salguero, Á., Iglesias‐Rey, R., Rodríguez‐Arrizabalaga, M., Fernández-Sanmartín, P., Castro‐Mosquera, M., Debasa‐Mouce, M., et al. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156160 · Cited by 11
Gut Microbiota Metabolite TMAO and Adolescent Cardiometabolic Health: A Cross-sectional Analysis
Iorra, F. D. Q., Rodrigues, P. G., Bock, P. M., Guahnon, M. P., Eller, S. C. W. D. S., de Oliveira, T. F., Birk, L., Schwarz, P. D. S., Drehmer, M., Bloch, K. V., et al. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf055 · Cited by 10
Waqar, M., Shahnawaz, M. B., Saleem, S., Dawood, H., Muhammad, U., & Dawood, H. (2025) · Algorithms · doi:10.3390/a18060333 · Cited by 16
Arnold, N., Goßling, A., Weimann, J., Bay, B., Zeller, T., Ferrario, M., Palmieri, L., Amouyel, P., Moitry, M., Ferrières, J., et al. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120475 · Cited by 14
The impact of sleep health on cardiovascular and all-cause mortality in the general population
Park, S. J., Park, J., Kim, B. S., & Park, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-15828-6 · Cited by 16
Wang, L., Pan, H., Cai, Z., Li, X., & Luo, L. (2025) · BMC Public Health · doi:10.1186/s12889-025-24300-z · Cited by 10
Gong, J. Y., Morton, J. I., Chen, L., Sacre, J. W., Carstensen, B., Gregg, E. W., Pavkov, M. E., Arffman, M., Booth, G. L., ter Braake, J. G., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00265-7 · Cited by 10
Maruyama, H., Iwasa, E., Watanabe, S., Hasegawa, T., Kajiyama, K., & Tanaka, T. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70142 · Cited by 11
“18 To address the potential impacts of unmeasured confounders and out- of-hospital fatal cases that were uncaptured in this claims database, we conducted two quantitative bias analyses.”
Wang, F., Wang, Z., Li, Y., Lyu, J., Qin, C., Wang, S., Guo, K., Sun, M., Huang, M., Zhang, H., et al. (2025) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2025.3641610 · Cited by 14
Supervía, M., Batalha, A. P. D. B., Gómez, E., Bonikowske, A. R., Riaño, M. O. A., & Ghisi, G. L. D. M. (2024) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2024.1495621 · Cited by 11
Hung, M. (2024) · Medicina · doi:10.3390/medicina60040566 · Cited by 10
Zieleniewicz, P., Wierucki, Ł., Kalarus, Z. F., Stokwiszewski, J., Grodzicki, T. K., Opolski, G., Sokal, A., & Zdrojewski, T. R. (2024) · Kardiologia Polska · doi:10.33963/v.phj.100639 · Cited by 12
Wang, Q., Ning, Y., Zhang, J., Du, X., Xu, Z., Hu, Y., Gao, F., & Chen, Y. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c07604 · Cited by 9
Polygenic Interactions With Environmental Exposures in Blood Pressure Regulation: The HUNT Study
Øvretveit, K., Ingeström, E., Spitieris, M., Tragante, V., Thomas, L. F., Steinsland, I., Brumpton, B. M., Gudbjartsson, D. F., Hólm, H., Stefánsson, K., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.034612 · Cited by 11
Ho, F. K. W., Dale, C. E., Mizani, M. A., Bolton, T., Pearson, E. R., Valabhji, J., Delles, C., Welsh, P. I., Nakada, S., Mackay, D., et al. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004485 · Cited by 11
Lee, J., Lin, Y., Chiang, P.-K., Lin, J., Jan, Y., Tsai, W., Chen, Y., & Wu, K. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13844 · Cited by 10
Qiu, Y., Zhao, P., Lin, X., Zeng, J., Wu, D., Yang, R., Fan, X., Liu, B., Hashimoto, K., Chang, L., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156988 · Cited by 9
Nakhebi, O. A. S. A., Kalinovic, R., Bosun, A., Neda-Stepan, O., Gliga, M., Crișan, C., Marinescu, I. P., Mornoş, C., & ENĂTESCU, V. R. (2025) · Life · doi:10.3390/life15071061 · Cited by 12
Lauder, L., Rahimi, K., Böhm, M., & Mahfoud, F. (2025) · Hypertension · doi:10.1161/hypertensionaha.125.25466 · Cited by 9
Second-Generation Aldosterone Synthase Inhibitors for Hypertension
de Queiroga, F. F., Araújo, B. B. C. S., Rivera, A., Consoli, L., Ujjawal, A., Mansouri, E. S., Akabane, M. A. C. C., Barrera, N. I., Ramos, A. B. V., Iqbal, A., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102621 · Cited by 12
Damigou, E., Chrysohoou, C. A., Vafia, C., Barkas, F., Kravvariti, E., Vlachopoulou, E., Kyrili, K., Tsioufis, C. P., Pitsavos, C. E., Liberopoulos, E. N., et al. (2023) · Nutrients · doi:10.3390/nu16010012 · Cited by 12
Asgari, S., Molavizadeh, D., Soltani, K., Khalili, D., Azizi, F., & Hadaegh, F. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01253-0 · Cited by 10
Saleh, Z. T., Aslanoğlu, A., Al-Dgheim., R., Sawalha, M., Elshatarat, R. A., Al‐Akash, H. Y., Almagharbeh, W. T., Al‐Sayaghi, K. M., Alhefnawy, K. A. H., Zaiton, H. I., et al. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00632 · Cited by 9
Gallucci, G., Larocca, M., Navazio, A., Turazza, F. M., Inno, A., Canale, M. L., Oliva, S., Besutti, G., Tedeschi, A., Aschieri, D., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010334 · Cited by 9
Yousif, G., Murugesan, S., Djekidel, M. N., Terranegra, A., Gentilcore, G., Grivel, J., & Khodor, S. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-87596-2 · Cited by 12
Hammoudeh, A., Aldalal’ah, M., Smadi, E. A., Alrishoud, D., Alomari, A. F., Alkhawaldeh, M., Rizik, A., Okour, M., & Araydah, M. (2025) · Vascular Health and Risk Management · doi:10.2147/vhrm.s499355 · Cited by 9
Cederqvist, J., Rådholm, K., Nyström, F. H., Engvall, J. E., Bergstrand, S., Fredriksson, I., Strömberg, T., & Östgren, C. J. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02628-5 · Cited by 10
Lee, H., Fernandes, M., Lee, J., Merino, J., & Kwak, S. H. (2025) · Diabetologia · doi:10.1007/s00125-025-06403-9 · Cited by 10
Lönnberg, L., Leppert, J., Ohrvik, J., Rehn, M., Chabok, A., & Damberg, M. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-081444 · Cited by 8
Wieprecht, J., Gomes, D., Vitale, F. M., Manai, S. K., Shamas, S., Müller, M., Baethmann, M., Tengler, A., Riley, R., Mandilaras, G., et al. (2025) · Children · doi:10.3390/children12050576 · Cited by 8
Song, J., Chi, K.-Y., Jeon, H., Chang, Y., Xanthavanij, N., Tang, Z., Chang, Y., Chiang, C., Lin, Y.-S., Lin, S., et al. (2025) · Oncology · doi:10.1159/000546204 · Cited by 9
Harpe, R. D. L., Marques-Vidal, P. M., & Vaucher, J. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf213 · Cited by 12
Goupil, R., Tsuyuki, R. T., Santesso, N. A., Terenzi, K. A., Habert, J., Cheng, G., Gysel, S. C., Bruneau, J., Leung, A. A. C., Campbell, N. R. C., et al. (2025) · Canadian Family Physician · doi:10.46747/cfp.20250616001 · Cited by 9
Kringeland, E. A., Midtbø, H. B., Ohldieck, A. E., Aune, A., & Gerdts, E. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf379 · Cited by 11
Han, Y.-N., Wang, Y., Xiong, C., Li, L., & Mao, R.-M. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1617287 · Cited by 8
Saito, Y., Tateishi, K., Kato, K., Kitahara, H., & Kobayashi, Y. (2025) · Internal Medicine · doi:10.2169/internalmedicine.5950-25 · Cited by 8
Hafzalla, G. W., Abramov, D., Shapiro, M. D., & Minhas, A. M. K. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101064 · Cited by 10
Veneziano, F. A., Gioia, F. A., & Gentile, F. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12090338 · Cited by 8
Sim, M., Webster, J., Smith, C., Saleem, A., Gilani, S. Z., Toro-Huamanchumo, C. J., Suter, D., Figtree, G. A., Lagendijk, A. K., Duncan, E. L., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2025.102570 · Cited by 8
Metadata
- Authors
- The Global Cardiovascular Risk Consortium
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- The Global Cardiovascular Risk Consortium
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-10-05
- Volume
- 389
- Issue
- 14
- Pages
- 1273-1285
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC10589462
- OpenAlex
- W4386194106
- Cited by
- 909
- References
- 35
- Citations by year
- 2026: 285 · 2025: 359 · 2024: 242 · 2023: 23
- FWCI
- 47.54
- Type
- journal article
- Language
- en
- Open access
- Licence
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
- Research Portal (Queen's University Belfast) (publishedVersion, cc-by)
- PubMed Central (acceptedVersion, cc-by)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Lithuanian University of Health Sciences (submittedVersion, cc-by)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- HAL (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Duo Research Archive (University of Oslo) (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- European Union AFFECT-EU (Horizon 2020, No. 847770)
- German Center for Cardiovascular Research (not applicable)
- European Union MORGAM (Biomed, BMH4-CT98-3183)
- European Union GenomEUtwin (FP5, QLG2-CT-2002-01254)
- European Union ENGAGE (FP7, HEALTH-F4-2007-201413)
- European Union CHANCES (FP7, HEALTH-F3-2010-242244)
- European Union BiomarCaRE (FP7, HEALTH-F2-2011-278913)
- European Union euCanSHare (Horizon 2020, No. 825903)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- modifiable risk factors, cardiovascular disease, all-cause mortality, population attributable fraction, body mass index, systolic blood pressure, non-HDL cholesterol, smoking, diabetes mellitus, sex differences, regional variation, global cardiovascular risk, cohort studies, cardiovascular disease incidence, women's health
- MeSH terms
- Heart Disease Risk Factors, Cardiovascular Diseases, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Risk Factors, Smoking, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.